On 7 April 2022, Glenmark Pharmaceuticals repurchased an aggregate principal amount of US$75,000,000 of the US$200,000,000 2.00 per cent Resettable Onward Starting Equity-linked Securities Due 2022 (ISIN: XS1426780125; Common Code: 142678012) (Bonds) (Repurchase).
The Repurchase was carried out by way of on-market purchases via The Hongkong and Shanghai Banking Corporation. The Bonds are listed on the Singapore Exchange Securities Trading.
The settlement and cancellation for the repurchased Bonds had completed on 7 April 2022. Following cancellation, the aggregate outstanding principal amount of the Bonds will be US$750,000.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
